RT Journal Article
SR Electronic
T1 Automated and Interpretable Detection of Hippocampal Sclerosis in temporal lobe epilepsy: AID-HS
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.13.23296991
DO 10.1101/2023.10.13.23296991
A1 Ripart, Mathilde
A1 DeKraker, Jordan
A1 Eriksson, Maria H
A1 Piper, Rory J.
A1 Mo, Jia-Jie
A1 Su, Ting-Yu
A1 Kochi, Ryuzaburo
A1 Wang, Irene
A1 Winston, Gavin P
A1 Clark, Chris A
A1 D’Arco, Felice
A1 Mankad, Kshitij
A1 Khan, Ali R.
A1 Baldeweg, Torsten
A1 Adler, Sophie
A1 Wagstyl, Konrad
YR 2023
UL http://medrxiv.org/content/early/2023/10/14/2023.10.13.23296991.abstract
AB Hippocampal Sclerosis (HS) can elude visual detection on MRI scans of patients with temporal lobe epilepsy (TLE), causing delays in surgical treatment and reducing the likelihood of postsurgical seizure-freedom. We developed an open-source software that (1) detects HS from structural MRI scans, (2) generalises across a heterogeneous multicentre cohort of children and adults, and (3) generates individualised predictions for clinical evaluation.We included a cohort of 363 participants (152 patients with HS, 90 disease controls with focal cortical dysplasia, and 121 healthy controls) from four epilepsy centres in the UK, North America, and China. We used the open-source software HippUnfold to extract morphological surface-based features and volumes of the hippocampus from T1w MRI scans. We compared pathological hippocampal morphology in patients with HS to normative growth charts generated from healthy controls, and to the contralateral hippocampi in patients with HS. HS was characterised by decreased volume, thickness and gyrification as well as increased mean and intrinsic curvature. A logistic regression classifier trained on these features detected 90.1% of HS patients, and accurately lateralised 97.4% of the HS cohort. Crucially, in patients with MRI-negative histopathologically confirmed HS, the classifier detected HS in 79.2% (19/24) and accurately lateralised the lesions in 91.7% (22/24). The Automated and Interpretable Detection of Hippocampal Sclerosis classifier (AID-HS) was packaged into an open-source pipeline, which detects and lateralises HS and generates individualised patient reports that characterise hippocampal developmental abnormalities.AID-HS is capable of accurately detecting and lateralising HS in a large, heterogeneous, multi-centre, cohort of paediatric and adult patients with diagnostically challenging HS. Moreover, by offering transparent, robust and interpretable results, AID-HS can support the presurgical evaluation of patients with suspected TLE.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMR and SA are supported by the Rosetrees Trust (A2665) and Epilepsy Research UK. KW is supported by the Welcome Trust (215901/Z/19/Z). GPW was supported by the MRC (G0802012, MR/M00841X/1). RJP is supported by the GOSH Childrens Charity (VS0221). AK is supported by the Canada Research Chairs program (950-231964), CIHR Project Grant 366062, and NSERC Discovery Grant RGPIN-2023-05558. JD is funded by a Natural Sciences and Engineering Research Council of Canada - Post-Doctoral Fellowship (NSERC-PDF). IW is supported by the National Institutes of Health (R01 NS109439). This work is supported by the NIHR GOSH BRC. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Joint Research & Development Office of Great Ormond Street Hospital (GOSH) and UCL Great Ormond Street Institute of Child Health (ICH) gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll code is available online to download on GitHub https://github.com/mathrip/AID-HS